684 results on '"Hughes, Steven J"'
Search Results
2. A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR
3. Impact of Biopsy Attempts, Race, and Access on Time to Initiation of Treatment for Pancreatic Cancer
4. Use of pancreatic endotherapy in patients with chronic pancreatitis: results from a multicenter cohort study in the United States
5. A protein-based machine learning approach to the identification of inflammatory subtypes in pancreatic ductal adenocarcinoma
6. Novel Calculator to Estimate the Risk of Clinically Relevant Postoperative Pancreatic Fistula Following Distal Pancreatectomy
7. The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma
8. The oral microbiome, pancreatic cancer and human diversity in the age of precision medicine
9. Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study
10. A risk-adjusted analysis of drain use in pancreaticoduodenectomy: Some is good, but more may not be better
11. Standard Operating Procedures for Biospecimen Collection, Processing, and Storage
12. A Prospective Study to Establish a New-Onset Diabetes Cohort
13. PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies
14. Supplementary Table S4 from Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression
15. Figure S2 from Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression
16. Table S2 from Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression
17. Data from Fibroblasts in the Aged Pancreas Drive Pancreatic Cancer Progression
18. The effect of high intraoperative blood loss on pancreatic fistula development after pancreatoduodenectomy: An international, multi-institutional propensity score matched analysis
19. Biliary intervention rates during neoadjuvant therapy for adenocarcinoma of the pancreatic head
20. Surgeon experience contributes to improved outcomes in pancreatoduodenectomies at high risk for fistula development
21. The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy
22. Impact of hospital volume on patient safety indicators and failure to rescue following open aortic aneurysm repair
23. From tumor microenvironment communicants to biomarker discovery: Selectively packaged extracellular vesicular cargoes in pancreatic cancer
24. Protein Signatures and Tissue Diagnosis of Pancreatic Cancer
25. Unique circulating immune signatures for recurrent acute pancreatitis, chronic pancreatitis and pancreatic cancer: A pilot study of these conditions with and without diabetes
26. Peptide-based capture-and-release purification of extracellular vesicles and statistical algorithm enabled quality assessment
27. Results of a phase II, open-label pilot study evaluating the safety and activity of liposomal irinotecan (Nal-IRI) in combination with 5-FU and oxaliplatin (NALIRIFOX) in preoperative treatment of pancreatic adenocarcinoma (NEO-Nal-IRI study).
28. Thermal ablation versus wedge or segmental resection in patients with early stage hepatocellular carcinoma: a population survival analysis
29. Interventions for Pancreatitis—New Approaches, Knowledge Gaps, and Research Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop.
30. Prognosis and Treatment Outcomes of Bone Metastasis in Gallbladder Adenocarcinoma: A SEER-Based Study
31. A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma
32. Changing Practice Patterns and Improving Survival for Patients with Pancreatic Ductal Adenocarcinoma
33. Break Scrub to Take That Phone Call?
34. Multicenter evaluation of the clinical utility of laparoscopy-assisted ERCP in patients with Roux-en-Y gastric bypass
35. The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy
36. The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy
37. Ethical Considerations of Biopsies in Early-Stage Pancreatic Cancer
38. A clinically applicable muscular index predicts long-term survival in resectable pancreatic cancer
39. Minimally invasive pancreatoduodenectomy
40. Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer.
41. Heterogeneity of weight loss and transcriptomic signatures in pancreatic ductal adenocarcinoma.
42. A Novel Amplicon at 8p22-23 Results in Overexpression of Cathepsin B in Esophageal Adenocarcinoma
43. Supplemental Figure S1 from Nicotine Reduces Survival via Augmentation of Paracrine HGF–MET Signaling in the Pancreatic Cancer Microenvironment
44. Data from Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment
45. Supplementary Figures 1 through 3 from Human Pancreatic Cancer Cells Induce a MyD88-Dependent Stromal Response to Promote a Tumor-Tolerant Immune Microenvironment
46. Isolation of Pancreatic Cancer Cells from a Patient-Derived Xenograft Model Allows for Practical Expansion and Preserved Heterogeneity in Culture
47. Relapsing Acute Pancreatitis Caused by a Mucinous Cystic Neoplasm
48. A phase II, open-label pilot study evaluating the safety and activity of liposomal irinotecan (Nal-IRI) in combination with 5-FU and oxaliplatin (NALIRIFOX) in preoperative treatment of pancreatic adenocarcinoma (NEO-Nal-IRI Study).
49. Low vs Standard-Dose Indocyanine Green in the Identification of Biliary Anatomy Using Near-Infrared Fluorescence Imaging: A Multicenter Randomized Controlled Trial
50. Primary outgrowth cultures are a reliable source of human pancreatic stellate cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.